查看购物车
  • Traditional Chinese
  • English
  • Japanese
封面
市场调查报告书
商品编码
1877613

2025年全球数位偏头痛治疗市场报告

Digital Therapeutics For Migraine Global Market Report 2025
出版日期: | 出版商: The Business Research Company | 英文 250 Pages | 商品交期: 2-10个工作天内

价格
简介目录

近年来，用于治疗偏头痛的数位疗法药物市场规模迅速扩张，预计将从2024年的13.7亿美元成长到2025年的17亿美元，复合年增长率达23.7%。这一增长被认为归因于以下因素：对个人化医疗解决方案的需求增加、人们对偏头痛作为一种神经系统疾病的认识提高、重视患者自我管理和监测、数位健康技术的进步以及远端医疗服务的扩展。

预计未来几年，偏头痛数位疗法市场将呈指数级增长，到2029年市场规模将达到39.2亿美元，复合年增长率（CAGR）为23.3%。预测期内的成长要素包括：数位健康解决方案的普及率不断提高、医疗服务提供者对数位疗法的认知度不断提升、患者对个人化治疗方案的需求日益增长、数位健康干预措施的报销政策不断扩大以及全球医疗保健支出不断增加。预测期内的主要趋势包括：人工智慧（AI）和机器学习在个人化医疗领域的进步、数位疗法与穿戴式装置的融合、用于偏头痛管理的行动医疗应用程式的开发、对循证数位健康干预措施的日益重视以及数位疗法监管核准的不断增加。

预计未来几年，智慧型手机普及率的不断提高将推动数位偏头痛药物市场的成长。智慧型手机是一种集通讯功能、强大的运算能力、网路存取和各种应用程式于一体的行动装置。由于其价格亲民且普及率高，智慧型手机的普及率持续上升，使用户能够更便捷地使用行动连线和数位医疗服务。智慧型手机的日益普及促进了数位偏头痛药物的推广应用，并使更多人能够获得基于应用程式的偏头痛管理和治疗方案。例如，根据英国产业协会GSMA于2023年2月发布的报告，撒哈拉以南非洲地区的智慧型手机普及率预计将从2022年的51%上升到2030年的87%。因此，智慧型手机普及率的提高正在推动数位偏头痛药物市场的成长。

为了改善治疗效果、提高患者依从性并满足日益增长的非药物偏头痛管理需求，偏头痛数位疗法市场的主要企业正致力于下一代创新，例如处方笺级行动软体。处方笺级行动软体是指经临床检验并获得监管机构核准的行动应用程序，可提供循证治疗性介入。例如，2025年4月，专注于处方笺数位疗法的美国公司Click Therapeutics, Inc.推出了CT-132，这是美国首个获得FDA批准的用于预防发作性偏头痛的处方笺数位疗法。这款受监管的行动应用程式透过基于软体的行为策略提供持续有效的偏头痛管理。它利用经临床检验的数位干预措施，帮助患者管理与压力相关的偏头痛诱因，并减少每月偏头痛发作天数。与传统的健康应用程式相比，CT-132有望提供更高的治疗效果、更强的患者依从性，并能无缝整合到正规医疗保健系统中。

目录

第一章执行摘要

第二章 市场特征

第三章 市场趋势与策略

第四章 市场：宏观经济情景，包括利率、通货膨胀、地缘政治、贸易战和关税，以及新冠疫情及其復苏对市场的影响

第五章 全球成长分析与策略分析框架

  • 全球偏头痛数位疗法：PESTEL 分析（政治、社会、科技、环境、法律因素、驱动因素和限制因素）
  • 终端用户产业分析
  • 全球数位偏头痛治疗市场：成长率分析
  • 全球数位偏头痛治疗市场表现：规模与成长，2019-2024年
  • 全球数位偏头痛治疗市场预测：规模与成长，2024-2029年，2034年预测
  • 全球数位偏头痛疗法：潜在市场规模 (TAM)

第六章 市场细分

  • 全球数位偏头痛治疗市场：依产品类型、表现及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 软体
  • 装置
  • 服务
  • 全球数位偏头痛治疗市场依患者类型、疗效及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 成人版
  • 适合儿童
  • 全球数位偏头痛治疗市场：依通路、绩效及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 医疗保健提供者
  • 线上平台
  • 药局
  • 全球数位偏头痛治疗市场：按应用、效能和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 预防
  • 急性治疗
  • 病患教育
  • 其他应用
  • 全球数位偏头痛治疗市场：依最终使用者、表现和预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 医院
  • 诊所
  • 居家照护
  • 其他最终用户
  • 全球数位偏头痛治疗市场：按软体类型、效能和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 行动应用
  • Web应用程式
  • 桌面应用程式
  • 全球数位偏头痛治疗市场：按装置类型、表现和预测进行细分，2019-2024 年、2024-2029 年预测、2034 年预测
  • 穿戴式装置
  • 监控设备
  • 治疗设备
  • 全球数位偏头痛治疗市场：按服务类型、表现和预测细分，2019-2024年、2024-2029年预测、2034年预测
  • 咨询服务
  • 教练服务
  • 支援服务

第七章 区域和国家分析

  • 全球数位偏头痛治疗市场：依地区、绩效及预测划分，2019-2024年、2024-2029年预测、2034年预测
  • 全球数位偏头痛治疗市场：国家/地区、绩效及预测，2019-2024年、2024-2029年预测、2034年预测

第八章 亚太市场

第九章：中国市场

第十章 印度市场

第十一章 日本市场

第十二章：澳洲市场

第十三章 印尼市场

第十四章 韩国市场

第十五章 西欧市场

第十六章英国市场

第十七章：德国市场

第十八章：法国市场

第十九章：义大利市场

第二十章：西班牙市场

第21章 东欧市场

第22章 俄罗斯市场

第23章 北美市场

第24章美国市场

第25章：加拿大市场

第26章 南美洲市场

第27章：巴西市场

第28章 中东市场

第29章：非洲市场

第三十章：竞争格局与公司概况

  • 数位偏头痛治疗市场：竞争格局
  • 数位偏头痛治疗市场：公司简介
    • Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Theranica Bio Electronics Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • Evidation Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • Aptar Digital Health SAS Overview, Products and Services, Strategy and Financial Analysis

第31章：其他领先和创新企业

  • Click Therapeutics Inc.
  • Salvia BioElectronics BV
  • Tonix Pharmaceuticals Holding Corp
  • Neurolief Ltd.
  • AndHealth LLC.
  • Nordic Brain Tech AS.
  • Curelator Inc.
  • Lin Health Inc.
  • Schmerzklinik Kiel GmbH.
  • Juva Health Inc.
  • Migrevention OU.
  • Newsenselab GmbH.
  • Ebby Health Inc.
  • Care Tuner Inc.
  • Peachy Day Inc.

第32章 全球市场竞争基准化分析与仪錶板

第33章 重大併购

第34章 近期市场趋势

第35章：高潜力市场国家、细分市场与策略

  • 2029年数位偏头痛治疗市场：提供新机会的国家
  • 2029年数位偏头痛治疗市场：提供新机会的细分市场
  • 2029年数位偏头痛治疗市场：成长策略
    • 基于市场趋势的策略
    • 竞争对手策略

第36章附录

简介目录
Product Code: r39198

Digital therapeutics for migraine is a software-based solution developed to prevent and manage migraine symptoms through personalized programs and digital interventions. It enables individuals to track headaches, receive behavioral guidance, and adopt healthier lifestyle habits to decrease migraine frequency. The solution facilitates real-time monitoring, enhances patient engagement, and delivers evidence-based therapy. Its goal is to improve quality of life and offer convenient, accessible care for individuals affected by migraines.

The primary product types of digital therapeutics for migraine include software, devices, and services. Software consists of clinically validated digital applications designed to provide evidence-based therapeutic interventions that assist in preventing or managing migraine symptoms. These solutions are intended for both adult and pediatric patients and are distributed through healthcare providers, online platforms, and pharmacies. Major applications include prevention, acute treatment, patient education, and others, with key end users being hospitals, clinics, homecare settings, and other healthcare facilities.

Note that the outlook for this market is being affected by rapid changes in trade relations and tariffs globally. The report will be updated prior to delivery to reflect the latest status, including revised forecasts and quantified impact analysis. The report's Recommendations and Conclusions sections will be updated to give strategies for entities dealing with the fast-moving international environment.

The sudden escalation of U.S. tariffs and the consequent trade frictions in spring 2025 are severely impacting the pharmaceutical companies contend with tariffs on APIs, glass vials, and lab equipment inputs with few alternative sources. Generic drug makers, operating on razor-thin margins, are especially vulnerable, with some reducing production of low-profit medicines. Biotech firms face delays in clinical trials due to tariff-related shortages of specialized reagents. In response, the industry is expanding API production in India and Europe, increasing inventory stockpiles, and pushing for trade exemptions for essential medicines.

The digital therapeutics for migraine market research report is one of a series of new reports from The Business Research Company that provides digital therapeutics for migraine market statistics, including the digital therapeutics for migraine industry global market size, regional shares, competitors with the digital therapeutics for migraine market share, detailed digital therapeutics for migraine market segments, market trends, and opportunities, and any further data you may need to thrive in the digital therapeutics for migraine industry. This digital therapeutics for migraine market research report delivers a complete perspective of everything you need, with an in-depth analysis of the current and future scenarios of the industry.

The digital therapeutics for migraine market size has grown exponentially in recent years. It will grow from $1.37 billion in 2024 to $1.70 billion in 2025 at a compound annual growth rate (CAGR) of 23.7%. Growth during the historic period can be attributed to the increasing demand for personalized healthcare solutions, rising awareness of migraine as a neurological disorder, greater emphasis on patient self-management and monitoring, advancements in digital health technologies, and the expansion of telemedicine services.

The digital therapeutics for migraine market size is expected to see exponential growth in the next few years. It will grow to $3.92 billion in 2029 at a compound annual growth rate (CAGR) of 23.3%. Growth during the forecast period can be attributed to the increasing adoption of digital health solutions, greater recognition of digital therapeutics among healthcare providers, rising patient preference for personalized treatment options, expansion of reimbursement policies for digital health interventions, and growing healthcare expenditure worldwide. Key trends anticipated during the forecast period include advancements in artificial intelligence and machine learning for personalized care, integration of digital therapeutics with wearable devices, development of mobile health applications for migraine management, emphasis on evidence-based digital health interventions, and a rise in regulatory approvals for digital therapeutics.

The increasing smartphone penetration is expected to drive the growth of the digital therapeutics for migraine market in the coming years. Smartphones are mobile devices that combine communication functions with advanced computing capabilities, internet access, and diverse applications. Smartphone penetration continues to rise due to greater affordability and widespread availability, enabling broader access to mobile connectivity and digital health services. The growing use of smartphones facilitates the adoption of digital therapeutics for migraine, making app-based management and therapy solutions more accessible to a larger population. For example, in February 2023, according to the GSM Association (GSMA), a UK-based industry organization representing mobile network operators and related companies, smartphone penetration in sub-Saharan Africa is projected to reach 87% by 2030, up from 51% in 2022. Therefore, the increasing smartphone penetration is contributing to the growth of the digital therapeutics for migraine market.

Leading companies in the digital therapeutics for migraine market are focusing on next-generation innovations such as prescription-grade mobile software to enhance treatment outcomes, improve patient adherence, and meet the rising demand for non-pharmacological migraine management. Prescription-grade mobile software refers to clinically validated mobile applications approved by regulatory authorities to deliver evidence-based therapeutic interventions. For instance, in April 2025, Click Therapeutics, Inc., a US-based company specializing in prescription digital therapeutics, launched CT-132, the first FDA-authorized prescription digital therapeutic for the preventive treatment of episodic migraine in the United States. This regulated mobile application offers sustained and effective migraine management through software-based behavioral strategies. It employs clinically validated digital interventions to help patients manage stress-related migraine triggers and reduce the frequency of migraine days per month. Compared to conventional wellness applications, CT-132 ensures higher treatment effectiveness, stronger patient adherence, and seamless integration into formal healthcare systems.

In February 2024, Aptar Digital Health, a US-based digital health solutions provider, acquired Healint for an undisclosed amount. This acquisition enables Aptar Digital Health to expand its portfolio in digital therapeutics and patient engagement solutions by integrating Healint's Migraine Buddy and Clarrio platforms, strengthening capabilities in real-world data collection, virtual clinical trials, and personalized patient care. Healint is a Singapore-based health technology company specializing in AI-powered digital therapeutics for neurological disorders.

Major players in the digital therapeutics for migraine market are Pfizer Inc., Theranica Bio Electronics Ltd., Dr. Reddy's Laboratories, Evidation Health Inc., Aptar Digital Health SAS, Click Therapeutics Inc., Salvia BioElectronics B.V., Tonix Pharmaceuticals Holding Corp, Neurolief Ltd., AndHealth LLC., Nordic Brain Tech AS., Curelator Inc., Lin Health Inc., Schmerzklinik Kiel GmbH., Juva Health Inc., Migrevention OU., Newsenselab GmbH., Ebby Health Inc., Care Tuner Inc., and Peachy Day Inc.

North America was the largest region in the digital therapeutics for migraine market in 2024. Asia-Pacific is expected to be the fastest-growing region in the forecast period. The regions covered in digital therapeutics for migraine report are Asia-Pacific, Western Europe, Eastern Europe, North America, South America, Middle East and Africa.

The countries covered in the digital therapeutics for migraine market report are Australia, Brazil, China, France, Germany, India, Indonesia, Japan, Russia, South Korea, UK, USA, Canada, Italy, Spain.

The digital therapeutics for migraine market consists of revenues earned by entities by providing services such as personalized migraine management programs, behavioral therapy modules, remote patient monitoring, headache tracking and analytics, patient education and engagement tools, digital cognitive behavioral therapy interventions, and real-time symptom management support. The market value includes the value of related goods sold by the service provider or included within the service offering. The digital therapeutics for migraine market also includes sales of mobile application platforms for migraine management, wearable devices for headache tracking, digital therapy software, cloud-based patient monitoring systems, interactive educational modules, and virtual consultation tools for migraine care. Values in this market are 'factory gate' values, that is, the value of goods sold by the manufacturers or creators of the goods, whether to other entities (including downstream manufacturers, wholesalers, distributors, and retailers) or directly to end customers. The value of goods in this market includes related services sold by the creators of the goods.

The market value is defined as the revenues that enterprises gain from the sale of goods and/or services within the specified market and geography through sales, grants, or donations in terms of the currency (in USD unless otherwise specified).

The revenues for a specified geography are consumption values that are revenues generated by organizations in the specified geography within the market, irrespective of where they are produced. It does not include revenues from resales along the supply chain, either further along the supply chain or as part of other products.

Digital Therapeutics For Migraine Global Market Report 2025 from The Business Research Company provides strategists, marketers and senior management with the critical information they need to assess the market.

This report focuses on digital therapeutics for migraine market which is experiencing strong growth. The report gives a guide to the trends which will be shaping the market over the next ten years and beyond.

Reasons to Purchase

  • Gain a truly global perspective with the most comprehensive report available on this market covering 15 geographies.
  • Assess the impact of key macro factors such as geopolitical conflicts, trade policies and tariffs, post-pandemic supply chain realignment, inflation and interest rate fluctuations, and evolving regulatory landscapes.
  • Create regional and country strategies on the basis of local data and analysis.
  • Identify growth segments for investment.
  • Outperform competitors using forecast data and the drivers and trends shaping the market.
  • Understand customers based on the latest market shares.
  • Benchmark performance against key competitors.
  • Suitable for supporting your internal and external presentations with reliable high quality data and analysis
  • Report will be updated with the latest data and delivered to you within 2-3 working days of order along with an Excel data sheet for easy data extraction and analysis.
  • All data from the report will also be delivered in an excel dashboard format.

Where is the largest and fastest growing market for digital therapeutics for migraine ? How does the market relate to the overall economy, demography and other similar markets? What forces will shape the market going forward, including technological disruption, regulatory shifts, and changing consumer preferences? The digital therapeutics for migraine market global report from the Business Research Company answers all these questions and many more.

The report covers market characteristics, size and growth, segmentation, regional and country breakdowns, competitive landscape, market shares, trends and strategies for this market. It traces the market's historic and forecast market growth by geography.

  • The market characteristics section of the report defines and explains the market.
  • The market size section gives the market size ($b) covering both the historic growth of the market, and forecasting its development.
  • The forecasts are made after considering the major factors currently impacting the market. These include:

The forecasts are made after considering the major factors currently impacting the market. These include the technological advancements such as AI and automation, Russia-Ukraine war, trade tariffs (government-imposed import/export duties), elevated inflation and interest rates.

  • Market segmentations break down the market into sub markets.
  • The regional and country breakdowns section gives an analysis of the market in each geography and the size of the market by geography and compares their historic and forecast growth.
  • The competitive landscape chapter gives a description of the competitive nature of the market, market shares, and a description of the leading companies. Key financial deals which have shaped the market in recent years are identified.
  • The trends and strategies section analyses the shape of the market as it emerges from the crisis and suggests how companies can grow as the market recovers.

Scope

  • Markets Covered:1) By Product Type: Software; Devices; Services
  • 2) By Patient Type: Adult; Pediatric
  • 3) By Distribution Channel: Healthcare Providers; Online Platforms; Pharmacies
  • 4) By Application: Prevention; Acute Treatment; Patient Education; Others Applications
  • 5) By End User: Hospitals; Clinics; Homecare; Others End Users
  • Subsegment:
  • 1) By Software: Mobile Applications; Web Applications; Desktop Applications
  • 2) By Devices: Wearable Devices; Monitoring Devices; Therapeutic Devices
  • 3) By Services: Consultation Services; Coaching Services; Support Services
  • Companies Mentioned: Pfizer Inc.; Theranica Bio Electronics Ltd.; Dr. Reddy's Laboratories; Evidation Health Inc.; Aptar Digital Health SAS; Click Therapeutics Inc.; Salvia BioElectronics B.V.; Tonix Pharmaceuticals Holding Corp; Neurolief Ltd.; AndHealth LLC.; Nordic Brain Tech AS.; Curelator Inc.; Lin Health Inc.; Schmerzklinik Kiel GmbH.; Juva Health Inc.; Migrevention OU.; Newsenselab GmbH.; Ebby Health Inc.; Care Tuner Inc.; Peachy Day Inc.
  • Countries: Australia; Brazil; China; France; Germany; India; Indonesia; Japan; Russia; South Korea; UK; USA; Canada; Italy; Spain.
  • Regions: Asia-Pacific; Western Europe; Eastern Europe; North America; South America; Middle East; Africa
  • Time Series: Five years historic and ten years forecast.
  • Data: Ratios of market size and growth to related markets, GDP proportions, expenditure per capita,
  • Data Segmentations: country and regional historic and forecast data, market share of competitors, market segments.
  • Sourcing and Referencing: Data and analysis throughout the report is sourced using end notes.
  • Delivery Format: PDF, Word and Excel Data Dashboard.

Table of Contents

1. Executive Summary

2. Digital Therapeutics For Migraine Market Characteristics

3. Digital Therapeutics For Migraine Market Trends And Strategies

4. Digital Therapeutics For Migraine Market - Macro Economic Scenario Including The Impact Of Interest Rates, Inflation, Geopolitics, Trade Wars and Tariffs, And Covid And Recovery On The Market

  • 4.1. Supply Chain Impact from Tariff War & Trade Protectionism

5. Global Digital Therapeutics For Migraine Growth Analysis And Strategic Analysis Framework

  • 5.1. Global Digital Therapeutics For Migraine PESTEL Analysis (Political, Social, Technological, Environmental and Legal Factors, Drivers and Restraints)
  • 5.2. Analysis Of End Use Industries
  • 5.3. Global Digital Therapeutics For Migraine Market Growth Rate Analysis
  • 5.4. Global Digital Therapeutics For Migraine Historic Market Size and Growth, 2019 - 2024, Value ($ Billion)
  • 5.5. Global Digital Therapeutics For Migraine Forecast Market Size and Growth, 2024 - 2029, 2034F, Value ($ Billion)
  • 5.6. Global Digital Therapeutics For Migraine Total Addressable Market (TAM)

6. Digital Therapeutics For Migraine Market Segmentation

  • 6.1. Global Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Software
  • Devices
  • Services
  • 6.2. Global Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Adult
  • Pediatric
  • 6.3. Global Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Healthcare Providers
  • Online Platforms
  • Pharmacies
  • 6.4. Global Digital Therapeutics For Migraine Market, Segmentation By Application, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Prevention
  • Acute Treatment
  • Patient Education
  • Others Applications
  • 6.5. Global Digital Therapeutics For Migraine Market, Segmentation By End User, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Hospitals
  • Clinics
  • Homecare
  • Others End Users
  • 6.6. Global Digital Therapeutics For Migraine Market, Sub-Segmentation Of Software By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Mobile Applications
  • Web Applications
  • Desktop Applications
  • 6.7. Global Digital Therapeutics For Migraine Market, Sub-Segmentation Of Devices By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Wearable Devices
  • Monitoring Devices
  • Therapeutic Devices
  • 6.8. Global Digital Therapeutics For Migraine Market, Sub-Segmentation Of Services By Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • Consultation Services
  • Coaching Services
  • Support Services

7. Digital Therapeutics For Migraine Market Regional And Country Analysis

  • 7.1. Global Digital Therapeutics For Migraine Market, Split By Region, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 7.2. Global Digital Therapeutics For Migraine Market, Split By Country, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

8. Asia-Pacific Digital Therapeutics For Migraine Market

  • 8.1. Asia-Pacific Digital Therapeutics For Migraine Market Overview
  • Region Information, Market Information, Background Information, Government Initiatives, Regulations, Regulatory Bodies, Major Associations, Taxes Levied, Corporate Tax Structure, Investments, Major Companies
  • 8.2. Asia-Pacific Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.3. Asia-Pacific Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 8.4. Asia-Pacific Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

9. China Digital Therapeutics For Migraine Market

  • 9.1. China Digital Therapeutics For Migraine Market Overview
  • 9.2. China Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.3. China Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion
  • 9.4. China Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F,$ Billion

10. India Digital Therapeutics For Migraine Market

  • 10.1. India Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.2. India Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 10.3. India Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

11. Japan Digital Therapeutics For Migraine Market

  • 11.1. Japan Digital Therapeutics For Migraine Market Overview
  • 11.2. Japan Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.3. Japan Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 11.4. Japan Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

12. Australia Digital Therapeutics For Migraine Market

  • 12.1. Australia Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.2. Australia Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 12.3. Australia Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

13. Indonesia Digital Therapeutics For Migraine Market

  • 13.1. Indonesia Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.2. Indonesia Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 13.3. Indonesia Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

14. South Korea Digital Therapeutics For Migraine Market

  • 14.1. South Korea Digital Therapeutics For Migraine Market Overview
  • 14.2. South Korea Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.3. South Korea Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 14.4. South Korea Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

15. Western Europe Digital Therapeutics For Migraine Market

  • 15.1. Western Europe Digital Therapeutics For Migraine Market Overview
  • 15.2. Western Europe Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.3. Western Europe Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 15.4. Western Europe Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

16. UK Digital Therapeutics For Migraine Market

  • 16.1. UK Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.2. UK Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 16.3. UK Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

17. Germany Digital Therapeutics For Migraine Market

  • 17.1. Germany Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.2. Germany Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 17.3. Germany Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

18. France Digital Therapeutics For Migraine Market

  • 18.1. France Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.2. France Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 18.3. France Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

19. Italy Digital Therapeutics For Migraine Market

  • 19.1. Italy Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.2. Italy Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 19.3. Italy Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

20. Spain Digital Therapeutics For Migraine Market

  • 20.1. Spain Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.2. Spain Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 20.3. Spain Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

21. Eastern Europe Digital Therapeutics For Migraine Market

  • 21.1. Eastern Europe Digital Therapeutics For Migraine Market Overview
  • 21.2. Eastern Europe Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.3. Eastern Europe Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 21.4. Eastern Europe Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

22. Russia Digital Therapeutics For Migraine Market

  • 22.1. Russia Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.2. Russia Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 22.3. Russia Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

23. North America Digital Therapeutics For Migraine Market

  • 23.1. North America Digital Therapeutics For Migraine Market Overview
  • 23.2. North America Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.3. North America Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 23.4. North America Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

24. USA Digital Therapeutics For Migraine Market

  • 24.1. USA Digital Therapeutics For Migraine Market Overview
  • 24.2. USA Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.3. USA Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 24.4. USA Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

25. Canada Digital Therapeutics For Migraine Market

  • 25.1. Canada Digital Therapeutics For Migraine Market Overview
  • 25.2. Canada Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.3. Canada Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 25.4. Canada Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

26. South America Digital Therapeutics For Migraine Market

  • 26.1. South America Digital Therapeutics For Migraine Market Overview
  • 26.2. South America Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.3. South America Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 26.4. South America Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

27. Brazil Digital Therapeutics For Migraine Market

  • 27.1. Brazil Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.2. Brazil Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 27.3. Brazil Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

28. Middle East Digital Therapeutics For Migraine Market

  • 28.1. Middle East Digital Therapeutics For Migraine Market Overview
  • 28.2. Middle East Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.3. Middle East Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 28.4. Middle East Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

29. Africa Digital Therapeutics For Migraine Market

  • 29.1. Africa Digital Therapeutics For Migraine Market Overview
  • 29.2. Africa Digital Therapeutics For Migraine Market, Segmentation By Product Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.3. Africa Digital Therapeutics For Migraine Market, Segmentation By Patient Type, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion
  • 29.4. Africa Digital Therapeutics For Migraine Market, Segmentation By Distribution Channel, Historic and Forecast, 2019-2024, 2024-2029F, 2034F, $ Billion

30. Digital Therapeutics For Migraine Market Competitive Landscape And Company Profiles

  • 30.1. Digital Therapeutics For Migraine Market Competitive Landscape
  • 30.2. Digital Therapeutics For Migraine Market Company Profiles
    • 30.2.1. Pfizer Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.2. Theranica Bio Electronics Ltd. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.3. Dr. Reddy's Laboratories Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.4. Evidation Health Inc. Overview, Products and Services, Strategy and Financial Analysis
    • 30.2.5. Aptar Digital Health SAS Overview, Products and Services, Strategy and Financial Analysis

31. Digital Therapeutics For Migraine Market Other Major And Innovative Companies

  • 31.1. Click Therapeutics Inc.
  • 31.2. Salvia BioElectronics B.V.
  • 31.3. Tonix Pharmaceuticals Holding Corp
  • 31.4. Neurolief Ltd.
  • 31.5. AndHealth LLC.
  • 31.6. Nordic Brain Tech AS.
  • 31.7. Curelator Inc.
  • 31.8. Lin Health Inc.
  • 31.9. Schmerzklinik Kiel GmbH.
  • 31.10. Juva Health Inc.
  • 31.11. Migrevention OU.
  • 31.12. Newsenselab GmbH.
  • 31.13. Ebby Health Inc.
  • 31.14. Care Tuner Inc.
  • 31.15. Peachy Day Inc.

32. Global Digital Therapeutics For Migraine Market Competitive Benchmarking And Dashboard

33. Key Mergers And Acquisitions In The Digital Therapeutics For Migraine Market

34. Recent Developments In The Digital Therapeutics For Migraine Market

35. Digital Therapeutics For Migraine Market High Potential Countries, Segments and Strategies

  • 35.1 Digital Therapeutics For Migraine Market In 2029 - Countries Offering Most New Opportunities
  • 35.2 Digital Therapeutics For Migraine Market In 2029 - Segments Offering Most New Opportunities
  • 35.3 Digital Therapeutics For Migraine Market In 2029 - Growth Strategies
    • 35.3.1 Market Trend Based Strategies
    • 35.3.2 Competitor Strategies

36. Appendix

  • 36.1. Abbreviations
  • 36.2. Currencies
  • 36.3. Historic And Forecast Inflation Rates
  • 36.4. Research Inquiries
  • 36.5. The Business Research Company
  • 36.6. Copyright And Disclaimer